Jafry Syed A. 4

What Happened
Jafry Syed A., a director of Zimmer Biomet Holdings, Inc. (ZBH), was granted 182.421 phantom stock units (derivative award) on March 31, 2026. The units were granted at no cash cost (reported price $0.00) and are recorded as derivative securities. The grant will convert on a 1-for-1 basis to company common stock and is to be settled in shares within sixty days after the reporting person stops serving as a director.

Key Details

• Transaction date: 2026-03-31; Transaction code: A (award/grant).
• Amount: 182.421 phantom stock units; reported acquisition price $0.00 (no cash paid).
• Conversion/exercise ratio: 1-for-1 (each unit converts to one share).
• Settlement: Units will be settled in shares within 60 days after cessation of director service.
• Footnote specifics: Units were accrued under the Zimmer Biomet Deferred Compensation Plan for Non-Employee Directors; includes additional phantom units from dividend reinvestment — 18.122 (7/31/2025), 17.223 (10/31/2025), and 20.035 (1/30/2026).
• Shares owned after transaction: not specified in the filing.
• Filing timeliness: Reported 2026-04-02 for a 2026-03-31 grant; filing appears timely (no late filing flag in the report).

Context
Phantom stock units are deferred compensation that track the company’s stock value and convert to actual shares (or cash/share equivalent) upon a future event (here, cessation of director service). This is a compensation grant, not an open-market purchase or sale, so it should be viewed as part of director pay rather than a direct market sentiment signal.